Alyeska Investment Group
LOXO

Alyeska Investment Group’s Loxo Oncology, Inc LOXO Stock Holding History

Alyeska Investment Group’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-53,302
Closed -$9.25M – 573
2018
Q2 		$9.25M Sell
53,302
-37,986
-42% -$5.71M 0.08% 214
2018
Q1 		$10.5M Sell
91,288
-6,178
-6% -$657K 0.09% 215
2017
Q4 		$8.21M Buy
97,466
+72,014
+283% +$6M 0.07% 225
2017
Q3 		$2.35M Sell
25,452
-24,548
-49% -$1.91M 0.02% 349
2017
Q2 		$4.01M Buy
+50,000
New +$2.77M 0.03% 297
2015
Q3 		– Sell
-79,545
Closed -$1.43M – 565
2015
Q2 		$1.43M Buy
79,545
+5,450
+7% +$74.5K 0.02% 376
2015
Q1 		$922K Buy
74,095
+5,446
+8% +$67.8K 0.01% 438
2014
Q4 		$807K Buy
68,649
+18,200
+36% +$212K 0.01% 410
2014
Q3 		$662K Buy
+50,449
New +$655K 0.01% 352

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Alyeska Investment Group's LOXO Position: Q3 2018 in Review

Alyeska Investment Group sold out of Loxo Oncology, Inc (LOXO) in Q3 2018, closing a stake of 53,302 shares — an estimated $9.25M sold.

Alyeska Investment Group first reported a position in LOXO in Q3 2014 and held it in 9 quarters. The position peaked at $10.5M in Q1 2018. 228 funds tracked by Wall St. Rank hold LOXO as of Q3 2018.

  • Alyeska Investment Group reported no remaining Loxo Oncology, Inc position as of Q3 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 53,302 Loxo Oncology, Inc shares in Q3 2018, an estimated $9.25M.
  • Alyeska Investment Group first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 9 quarters.
  • Alyeska Investment Group's Loxo Oncology, Inc position peaked at $10.5M in Q1 2018.
  • 228 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2018.

Based on Alyeska Investment Group's 13F filing for Q3 2018, filed 14 Nov 2018.